Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats

Toxicology

Volumn 273, Issue 1-3, 2010, Pages 53-59

  Tonomura, Yutaka ^a   Tsuchiya, Noriko ^a   Torii, Mikinori ^a   Uehara, Takeki ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Cisplatin; Glomerular injury; Puromycin aminonucleoside; Renal tubular injury; Urinary biomarkers

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; CISPLATIN; CLUSTERIN; CREATININE; CYSTATIN C; GLUTATHIONE TRANSFERASE ALPHA; KIDNEY INJURY MOLECULE 1; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN; PUROMYCIN AMINONUCLEOSIDE; UREA; ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; GLUTATHIONE TRANSFERASE; HAVCR1PROTEIN, RAT; LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN PROTEIN, RAT; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PROTEIN, RAT; ONCOPROTEIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; GLOMERULOPATHY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MALE; NEPHRON; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TOXICITY TESTING; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECT; EVALUATION; GLOMERULUS; KIDNEY; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SPRAGUE DAWLEY RAT; URINE;

RATTUS;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; ALBUMINURIA; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CELL ADHESION MOLECULES; CISPLATIN; CLUSTERIN; CREATININE; CYSTATIN C; GLUTATHIONE TRANSFERASE; KIDNEY; KIDNEY GLOMERULUS; L-LACTATE DEHYDROGENASE; LIPOCALINS; MALE; PROTEINURIA; PROTO-ONCOGENE PROTEINS; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, SPRAGUE-DAWLEY; ROC CURVE;

EID: 77953236059     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.04.015     Document Type: Article

References (45)

1. Bailly V., Zhang Z., Meier W., Cate R., Sanicola M., Bonventre J.V. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 2002, 277:39739-39748.
2. Birn H., Christensen E.I. Renal albumin absorption in physiology and pathology. Kidney Int. 2006, 69:440-449.
3. Bonventre J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J. Am. Soc. Nephrol. 2003, 14:S55-S61.
4. Bonventre J.V. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol. Dial. Transplant. 2009, 24:3265-3268.
5. Christensen E.I., Willnow T.E. Essential role of megalin in renal proximal tubule for vitamin homeostasis. J. Am. Soc. Nephrol. 1999, 10:2224-2236.
6. Conti M., Moutereau S., Zater M., Lallali K., Durrbach A., Manivet P., Eschwège P., Loric S. Urinary cystatin C as a specific marker of tubular dysfunction. Clin. Chem. Lab. Med. 2006, 44:288-291.
7. Cui S., Verroust P.J., Moestrup S.K., Christensen E.I. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am. J. Physiol. 1996, 271:F900-F907.
8. D'Amico G., Bazzi C. Pathophysiology of proteinuria. Kidney Int. 2003, 63:809-825.
9. Dieter M.P., Boorman G.A., Jameson C.W., Eustis S.L., Uraih L.C. Development of renal toxicity in F344 rats gavaged with mercuric chloride for 2 weeks, or 2, 4, 6, 15, and 24 months. J. Toxicol. Environ. Health 1992, 36:319-340.
10. Eng, J., 2006. ROC analysis: web-based calculator for ROC curves. http://www.rad.jhmi.edu/jeng/javarad/roc/JROCFITi.html.
11. European Medicines Agency (EMEA), 2008. Final report on the pilot joint EMEA/FDA VXDs experience on qualification of nephrotoxicity biomarkers. http://www.emea.europa.eu/pdfs/human/biomarkers/25088508en.pdf.
12. Food and Drug Administration (FDA), 2008. FDA, European Medicines Agency to Consider Additional Test Results When Assessing New Drug Safety. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116911.htm.
13. Gauthier C., Nguyen-Simonnet H., Vincent C., Revillard J.P., Pellet M.V. Renal tubular absorption of beta 2 microglobulin. Kidney Int. 1984, 26:170-175.
14. Greive K.A., Nikolic-Paterson D.J., Guimarães M.A., Nikolovski J., Pratt L.M., Mu W., Atkins R.C., Comper W.D. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. Am. J. Pathol. 2001, 159:1159-1170.
15. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol. 1992, 38:S20-S27.
16. Guder W.G., Ross B.D. Enzyme distribution along the nephron. Kidney Int. 1984, 26:101-111.
17. Gumbleton M., Nicholls P.J. Dose-response and time-response biochemical and histological study of potassium dichromate-induced nephrotoxicity in the rat. Food Chem. Toxicol. 1988, 26:37-44.
18. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 2009, 54:1012-1024. NGAL Meta-analysis Investigator Group.
19. Han W.K., Bailly V., Abichandani R., Thadhani R., Bonventre J.V. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002, 62:237-244.
20. Herget-Rosenthal S., van Wijk J.A., Bröcker-Preuss M., Bökenkamp A. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin. Biochem. 2007, 40:946-951.
21. Hvidberg V., Jacobsen C., Strong R.K., Cowland J.B., Moestrup S.K., Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005, 579:773-777.
22. Ichimura T., Hung C.C., Yang S.A., Stevens J.L., Bonventre J.V. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 2004, 286:F552-F563.
23. International Life Sciences Institute Health and Environmental Sciences Institute (ILSI-HESI), 2008. Project committee on the development and application of biomarkers of nephrotoxicity. http://www.hesiglobal.org/files/public/Factsheets/BIOMARKERS-NephrotoxFactsheet0409.pdf.
24. Jones T.W., Chopra S., Kaufman J.S., Flamenbaum W., Trump B.F. Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations. Lab. Invest. 1985, 52:363-374.
25. Kuhlmann M.K., Burkhardt G., Köhler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol. Dial. Transplant. 1997, 12:2478-2480.
26. Kuwabara T., Mori K., Mukoyama M., Kasahara M., Yokoi H., Saito Y., Yoshioka T., Ogawa Y., Imamaki H., Kusakabe T., Ebihara K., Omata M., Satoh N., Sugawara A., Barasch J., Nakao K. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009, 75:285-294.
27. Lannigan R., Kark R., Pollak V.E. The effect of a single intravenous injection of aminonucleoside of puromycin on the rat kidney: a light- and electron-microscope study. J. Pathol. Bacteriol. 1962, 83:357-362.
28. Mishra J., Mori K., Ma Q., Kelly C., Yang J., Mitsnefes M., Barasch J., Devarajan P. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 2004, 15:3073-3082.
29. Mori K., Lee H.T., Rapoport D., Drexler I.R., Foster K., Yang J., Schmidt-Ott K.M., Chen X., Li J.Y., Weiss S., Mishra J., Cheema F.H., Markowitz G., Suganami T., Sawai K., Mukoyama M., Kunis C., D'Agati V., Devarajan P., Barasch J. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 2005, 115:610-621.
30. Mori K., Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007, 71:967-970.
31. Portman R.J., Kissane J.M., Robson A.M. Use of beta 2 microglobulin to diagnose tubulo-interstitial renal lesions in children. Kidney Int. 1986, 30:91-98.
32. Prozialeck W.C., Edwards J.R., Lamar P.C., Liu J., Vaidya V.S., Bonventre J.V. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol. Appl. Pharmacol. 2009, 238:306-314.
33. Rozell B., Hansson H.A., Guthenberg C., Tahir M.K., Mannervik B. Glutathione transferases of classes alpha, mu and pi show selective expression in different regions of rat kidney. Xenobiotica 1993, 23:835-849.
34. Russo L.M., Sandoval R.M., McKee M., Osicka T.M., Collins A.B., Brown D., Molitoris B.A., Comper W.D. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int. 2007, 71:504-513.
35. Sahni V., Choudhury D., Ahmed Z. Chemotherapy-associated renal dysfunction. Nat. Rev. Nephrol. 2009, 5:450-462.
36. Schmidt-Ott K.M., Mori K., Li J.Y., Kalandadze A., Cohen D.J., Devarajan P., Barasch J. Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 2007, 18:407-413.
37. Stonard M.D., Gore C.W., Oliver G.J., Smith I.K. Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney. Fundam. Appl. Toxicol. 1987, 9:339-351.
38. Takano M., Nakanishi N., Kitahara Y., Sasaki Y., Murakami T., Nagai J. Cisplatin-induced inhibition of receptor-mediated endocytosis of protein in the kidney. Kidney Int. 2002, 62:1707-1717.
39. Tonomura Y., Mori Y., Torii M., Uehara T. Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats. Toxicology 2009, 266:48-54.
40. Tripepi G., Jager K.J., Dekker F.W., Zoccali C. Diagnostic methods 2: receiver operating characteristic (ROC) curves. Kidney Int. 2009, 76:252-256.
41. Uehara T., Watanabe H., Itoh F., Inoue S., Koshida H., Nakamura M., Yamate J., Maruyama T. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Arch. Toxicol. 2005, 79:451-460.
42. Vaidya V.S., Ramirez V., Ichimura T., Bobadilla N.A., Bonventre J.V. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 2006, 290:F517-F529.
43. Zhang J., Goering P.L., Espandiari P., Shaw M., Bonventre J.V., Vaidya V.S., Brown R.P., Keenan J., Kilty C.G., Sadrieh N., Hanig J.P. Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine. Toxicol. Pathol. 2009, 37:629-643.
44. Zhang Z., Humphreys B.D., Bonventre J.V. Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J. Am. Soc. Nephrol. 2007, 18:2704-2714.
45. Zhou Y., Vaidya V.S., Brown R.P., Zhang J., Rosenzweig B.A., Thompson K.L., Miller T.J., Bonventre J.V., Goering P.L. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol. Sci. 2008, 101:159-170.